11β,16α,17,21-Tetrahydroxypregn-4-en-3,20-dion
11beta,16alpha,17,21-Tetrahydroxypregn-4-ene-3,20-dione
Grundinformationen
- CAS
1171-81-9- Standard-SMILES
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@@H](O)[C@]2(O)C(=O)CO- InChIKey
SQPRYYSTJMNHSK-ILNISADRSA-N- Summenformel
- C21H30O6
- Durchschnittliche Molmasse
- 378,5 g/mol
- Monoisotopische Masse
- 378,20423868
Namen und Bezeichner
- Bevorzugter Name
- 11beta,16alpha,17,21-Tetrahydroxypregn-4-ene-3,20-dione
- IUPAC
- (8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- Lokaler Name
- 11β,16α,17,21-Tetrahydroxypregn-4-en-3,20-dion
- Englischer Name
- 11beta,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
- Summenformel
- C21H30O6
- Molmasse
- 378.4593
Namen und Synonyme
1171-81-911beta,16alpha,17,21-Tetrahydroxypregn-4-ene-3,20-dione(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-oneEINECS 214-627-4SCHEMBL141635DTXSID90922287SQPRYYSTJMNHSK-ILNISADRSA-NFH165346NS00044751H81072F571466
Weitere Namen anzeigen
-Hydroxycortisol16α-Hydroxycortisol16a-HydroxycortisolBudesonide Impurity 41Budesonide Impurity 54Budesonide Impurity 1016Alpha-HydroxycortisolBudesonide EP Impurity 1011β,16α,17,21-Tetrahydroxypregn-4-ene-3,20-dione
11,16,17,21-tetrahydroxypregn-4-ene-3,20-dione
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,2
- Polarare Oberfläche (TPSA)
- 115 Ų
- H-Brücken-Donoren
- 4
- H-Brücken-Akzeptoren
- 6
- Frei drehbare Bindungen
- 2
- Schwere Atome
- 27
- Formalladung
- 0
- Komplexität
- 715
Experimentelle und physikochemische Eigenschaften
Endocrine DisruptorsPotential endocrine disrupting compound
Physikochemische Eigenschaften
- Schmelzpunkt
- 217 °C · >217°C (dec.)
- Siedepunkt
- 587.1 · 587.1±50.0 °C(Predicted)
- Dichte
- 1.35 · 1.35±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · -20°C Freezer
- Löslichkeit
- DMSO (slightly), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 11.94 · 11.94±0.70(Predicted)
- Farbe
- White to Off-White
Chemie und Industrie
Anwendungen
Verwenden11β,16α,17,21-Tetrahydroxypregn-4-ene-3,20-dione is a metabolite of Hydroxycortisone (H714615), a steroid hormone, more specifically a glucocorticoid, produced by the zona fasciculata of the adrenal gland. Its primary functions are to increase blood sugar through gluconeogenesis; suppress the immune system; and aid in fat, protein and carbohydrate metabolism.
Anbieter26 Anbieter
广州佳途科技股份有限公司81960175-877 18933936954 · [email protected]
清宁生物（江苏博泉生物科技有限公司）王 19352250998 13160238781 · [email protected]
廊坊市恒福源医药科技有限公司0316-2883537 19333636468 · [email protected]
廊坊市泽康医药科技有限公司0316-2883536 19333636468 · [email protected]
北京康派森医药科技有限公司010-010-52878169 15801002657 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Wuhan Jingkang en Biomedical Technology Co., Ltd+86-0086-13720134139 · [email protected]
TLC梯尔希（南京）药物研发有限公司18012923235 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
安耐吉化学&3A（安徽泽升科技股份有限公司）400-0056266 · [email protected]
Zugehörige Reaktionen
2
Notizen zur Verbindung
Wird geladen…